Postoperative Patient Comfort and Quality of Micturition in Suprapubic Tube vs. Transurethral Catheterization After RARP
NCT ID: NCT02812173
Last Updated: 2022-12-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
234 participants
INTERVENTIONAL
2016-05-31
2018-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Randomized Trial Comparing Urinary Diversion After Robot-assisted Radical Prostatectomy
NCT02108431
The Robot-Assisted Laparoscopic Radical Prostatectomy Combined Anterior and Posterior Approach
NCT06020287
The Impact of Low Pressure Pneumo in RARP
NCT03370016
Impact of Augmented Reality During Robot-assisted Radical Prostatectomy
NCT06059859
RCT-evaluation of Retzius-sparing Robotic Prostatectomy
NCT03787823
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
suprapubic tube ex 2 day
patients who underwent robot-assisted radical prostatectomy and got intraoperatively, a suprapubic tube, which was withdrawn on the 2th day after the surgery
suprapubic tube ex 2 day
balloon catheter for suprapubic bladder-drainage, suprapubic tube removal on the second day after the surgery
suprapubic tube ex 5 day
patients who underwent robot-assisted radical prostatectomy and got intraoperatively, a suprapubic tube, which was withdrawn on the 5th day after the surgery
suprapubic tube ex 5 day
balloon catheter for suprapubic bladder-drainage, suprapubic tube removal on the fifth day after the surgery
transurethral catheter ex 5 day
patients who underwent robot-assisted radical prostatectomy and got intraoperatively, a transurethral catheter, which was withdrawn on the 5th day after the surgery
transurethral catheter ex 5 day
transurethral catheter withdrawal removal on the fifth day after the surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
suprapubic tube ex 2 day
balloon catheter for suprapubic bladder-drainage, suprapubic tube removal on the second day after the surgery
suprapubic tube ex 5 day
balloon catheter for suprapubic bladder-drainage, suprapubic tube removal on the fifth day after the surgery
transurethral catheter ex 5 day
transurethral catheter withdrawal removal on the fifth day after the surgery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Voluntarily agreement to participate in this study
* filled in and signed Informed Consent
* release of medical records for regulatory or research purposes
* clinically organ-confined prostate cancer
* recommended and planned robot-assisted radical prostatectomy
Exclusion Criteria
* International Prostate Symptom Score (IPPS) \> 18
* History of radiation or chemotherapy
* History of transurethral prostate resection
* unable to provide informed consent
* unwillingness to storage and forwarding of pseudonymous data
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Antonius Hospital Gronau
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nina Harke, MD.
Role: PRINCIPAL_INVESTIGATOR
St. Antonius Hospital Gronau
Mustapha Addali, MD.
Role: STUDY_CHAIR
St. Antonius Hospital Gronau
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Urology, Pediatric Urology and Urologic Oncology, St. Antonius Hospital Gronau
Gronau, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U4DGYZXT2DBN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.